Hui E - Search Results

1

Antigen-Presenting Cell-Intrinsic PD-1 Neutralizes PD-L1 in cis to Attenuate PD-1 Signaling in T Cells.

Zhao Y, Harrison DL, Song Y, Ji J, Huang J, Hui E. Zhao Y, et al. Among authors: hui e. Cell Rep. 2018 Jul 10;24(2):379-390.e6. doi: 10.1016/j.celrep.2018.06.054. Cell Rep. 2018. PMID: 29996099 Free PMC article.

2

T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition.

Hui E, Cheung J, Zhu J, Su X, Taylor MJ, Wallweber HA, Sasmal DK, Huang J, Kim JM, Mellman I, Vale RD. Hui E, et al. Science. 2017 Mar 31;355(6332):1428-1433. doi: 10.1126/science.aaf1292. Epub 2017 Mar 9. Science. 2017. PMID: 28280247 Free PMC article.

3

Immune checkpoint inhibitors.

Hui E. Hui E. J Cell Biol. 2019 Mar 4;218(3):740-741. doi: 10.1083/jcb.201810035. Epub 2019 Feb 13. J Cell Biol. 2019. PMID: 30760493 Free PMC article. Review.

4

Understanding T cell signaling using membrane reconstitution.

Hui E. Hui E. Immunol Rev. 2019 Sep;291(1):44-56. doi: 10.1111/imr.12767. Immunol Rev. 2019. PMID: 31402497 Review.

5

TCR-pMHC bond conformation controls TCR ligand discrimination.

Sasmal DK, Feng W, Roy S, Leung P, He Y, Cai C, Cao G, Lian H, Qin J, Hui E, Schreiber H, Adams EJ, Huang J. Sasmal DK, et al. Among authors: hui e. Cell Mol Immunol. 2020 Mar;17(3):203-217. doi: 10.1038/s41423-019-0273-6. Epub 2019 Sep 17. Cell Mol Immunol. 2020. PMID: 31530899 Free PMC article.

6

PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways.

Zhao Y, Lee CK, Lin CH, Gassen RB, Xu X, Huang Z, Xiao C, Bonorino C, Lu LF, Bui JD, Hui E. Zhao Y, et al. Among authors: hui e. Immunity. 2019 Dec 17;51(6):1059-1073.e9. doi: 10.1016/j.immuni.2019.11.003. Epub 2019 Nov 19. Immunity. 2019. PMID: 31757674 Free PMC article.

7

PD-1 and BTLA regulate T cell signaling differentially and only partially through SHP1 and SHP2.

Xu X, Hou B, Fulzele A, Masubuchi T, Zhao Y, Wu Z, Hu Y, Jiang Y, Ma Y, Wang H, Bennett EJ, Fu G, Hui E. Xu X, et al. Among authors: hui e. J Cell Biol. 2020 Jun 1;219(6):e201905085. doi: 10.1083/jcb.201905085. J Cell Biol. 2020. PMID: 32437509 Free PMC article.

8

Multiple Signaling Roles of CD3ε and Its Application in CAR-T Cell Therapy.

Wu W, Zhou Q, Masubuchi T, Shi X, Li H, Xu X, Huang M, Meng L, He X, Zhu H, Gao S, Zhang N, Jing R, Sun J, Wang H, Hui E, Wong CC, Xu C. Wu W, et al. Among authors: hui e. Cell. 2020 Aug 20;182(4):855-871.e23. doi: 10.1016/j.cell.2020.07.018. Epub 2020 Jul 29. Cell. 2020. PMID: 32730808 Free article.

9

Molecular features underlying differential SHP1/SHP2 binding of immune checkpoint receptors.

Xu X, Masubuchi T, Cai Q, Zhao Y, Hui E. Xu X, et al. Among authors: hui e. Elife. 2021 Nov 4;10:e74276. doi: 10.7554/eLife.74276. Elife. 2021. PMID: 34734802 Free PMC article.

10

Enhancing the therapeutic efficacy of programmed death ligand 1 antibody for metastasized liver cancer by overcoming hepatic immunotolerance in mice.

Xin B, Yang M, Wu P, Du L, Deng X, Hui E, Feng GS. Xin B, et al. Among authors: hui e. Hepatology. 2022 Sep;76(3):630-645. doi: 10.1002/hep.32266. Epub 2022 Jan 23. Hepatology. 2022. PMID: 34860431 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

575 results

Search Page